Cogniciti plays central role in pharma’s fight against dementia

Care Research

“Cogniciti’s online brain health assessment offers Baycrest the chance to play a central role in the development of the next generation of Alzheimer’s disease treatment. Finding the right research volunteers for studies has been a major problem. Through Cogniciti, users can now join a Research Registry designed to use their test results to match interested volunteers to the right studies.”

                                                                    -Michael Meagher, President and CEO of Cogniciti

The free, scientifically-validated test, developed by Rotman Research Institute scientists, can help adults 40+ determine if their memory changes should be evaluated by a doctor.

Over the past year, Cogniciti has signed agreements to recruit for two global drug studies and two non-drug studies at the Rotman Research Institute, all focused on therapies designed to lower the risk of Alzheimer’s Disease. Since its launch in 2013, more than 55,000 assessments were completed.

Take Cogniciti’s free online Brain Health Assessment or join the Research Registry at